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Lipid droplet proteomeCaloric restriction and intermittent fasting are known to improve glucose homeostasis and insulin resistance in
several species including humans. The aim of this study was to unravel potential mechanisms by which these
interventions improve insulin sensitivity and protect from type 2 diabetes. Diabetes-susceptible New Zealand
Obese mice were either 10% calorie restricted (CR) or fasted every other day (IF), and compared to ad libitum
(AL) fed control mice. AL mice showed a diabetes prevalence of 43%, whereas mice under CR and IF were
completely protected against hyperglycemia. Proteomic analysis of hepatic lipid droplets revealed signiﬁcantly
higher levels of PSMD9 (co-activator Bridge-1), MIF (macrophage migration inhibitor factor), TCEB2 (transcrip-
tion elongation factor B (SIII), polypeptide 2), ACY1 (aminoacylase 1) and FABP5 (fatty acid binding protein 5),
and a marked reduction of GSTA3 (glutathione S-transferase alpha 3) in samples of CR and IF mice. In addition,
accumulation of diacylglycerols (DAGs) was signiﬁcantly reduced in livers of IF mice (P = 0.045) while CR
mice showed a similar tendency (P= 0.062). In particular, 9 DAG species were signiﬁcantly reduced in response
to IF, of which DAG-40:4 and DAG-40:7 also showed signiﬁcant effects after CR. This was associated with a
decreased PKCε activation and might explain the improved insulin sensitivity. In conclusion, our data indicate
that protection against diabetes upon caloric restriction and intermittent fasting associates with a modulation
of lipid droplet protein composition and reduction of intracellular DAG species.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Type 2 diabetes (T2D) is ametabolic disorder that has becomeone of
the major challenges of health care systems. The onset of this disease is
dependent on the interplay of a subject's genetic background and the
environment, and characterized by hyperglycemia as a consequence of
inability of pancreatic beta-cells to secrete adequate amounts of insulin.
This process is driven by overnutrition and inactivity, leading to
overweight or obesity, and ﬁnally to insulin resistance and beta-cell
dysfunction. In consideration of the fact of an increasing prevalence
of T2D (592 million affected people estimated for 2035 [1]), it is ofDAG, diacylglycerol; HOMA-IR,
, intermittent fasting; LD, lipid
l Diabetology, German Institute
D-14558 Nuthetal, Germany.
.
. This is an open access article underparticular importance to develop prevention strategies to circumvent
this pandemic development.
One of the major theories linking obesity and insulin resistance is
lipotoxicity, an increased accumulation of intracellular lipids in non-
adipose tissues. Metabolically active lipid intermediates such as diacyl-
glycerols (DAGs) [2,3], ceramides [4], long chain fatty acyl-CoAs [5] and
acylcarnitines [6] are discussed to be involved in the suppression of
insulin sensitivity. Increased accumulation of intracellular fat is depen-
dent on storage and hydrolysis of neutral lipids,which in turn is regulat-
ed by lipid droplet (LD) associated proteins [7]. Since synthesis of toxic
lipid intermediates is regulated by LD proteins, composition of LDs also
plays a role in protection from lipotoxins [8,9]. However, in addition to
some prominent LD proteins, such as perilipins [10], CIDE proteins [11],
or PNLPA3 lipase [12], very little is known about the hepatic LD compo-
sition and its role in lipotoxicity and insulin resistance.
As increased dietary intake is known to be a strong risk factor for
insulin resistance and T2D, it is obvious that interventions such as a
limited energy intake are promising approaches for improving insulinthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
TaqMan assays used in quantitative real-time PCR.
Gene TaqMan probe
Fasn Mm00662319_m1
Acaca Mm01304277_m1
Scd1 Mm01197142_m1
Lipe Mm00495359_m1
Pnpla2 Mm00503040_m1
Eef2 Mm01171434_g1
Table 2
List of antibodies used in immunohistochemistry and Western blot experiments.
Primary antibody Dilution Host species Company
PLIN2 1/500 Guinea pig Progen
PKCε 1/1000 Mouse BD Transduction
CGI 58 1/250 Mouse Santa Cruz
ATGL 1/1000 Rabbit Cell Signaling
E-Cadherin 1/2500 Mouse BD Transduction
Syntaxin-6 1/2000 Mouse BD Transduction
Calnexin 1/2000 Rabbit Abcam
GAPDH 1/10,000 Mouse Ambion
PSMD9 (Bridge-1) 1/200 Rabbit Santa Cruz
MIF 1/2000 Rabbit Abcam
FABP5 1/1000 Rabbit Abcam
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termittent fasting (IF) are two procedures of dietary restriction known
for several beneﬁcial effects on health and longevity [13,14]. Several
studies in rodents and primates have shown that the reduction of
daily caloric intake by 10–40% improves insulin sensitivity, reduces
fasting glucose and insulin concentration and prevents obesity, T2D,
hypertension and chronic inﬂammation [15–17]. In humans, 20% CR
improves glucose tolerance and insulin action, and reduces risk factors
for T2D, cardiovascular disease and cancer [18,19]. Furthermore, IF in
rodents has been shown to prevent and reverse several indications of
themetabolic syndrome, such as impaired insulin sensitivity, hypergly-
cemia, adiposity and T2D [20–22]. However, molecular mechanisms of
CR and IF on lipotoxicity, LD composition, insulin sensitivity and T2D
prevalence have not been identiﬁed.
In the present study, we applied amoderate caloric restriction (10%)
or an intermittent fasting regimen to New Zealand Obese (NZO)mice, a
model for obesity,metabolic syndrome and T2D [23], and demonstrated
that both interventions are sufﬁcient to prevent the development of
T2D, to modulate hepatic LD protein composition, and to reduce DAG
levels.
2. Materials and methods
2.1. Animals
Male NZO/HIBomDife mice were fed a high-fat diet (33 kcal% fat,
49 kcal% carbohydrate, 18 kcal% protein; S8022-E080 unsat.FA; Ssniff)
ad libitum (AL), with 90% of the food consumed by AL mice (CR), or
every other day (IF). Food was provided or removed daily at 4 p.m.
Water was continuously available for all groups. The animals were
kept in a 12 hour light/12 hour dark cycle and in accordance with EU
Directive 2010/63/EU guidelines for the care and use of laboratory
animals. All experiments were approved by the ethics committee of
the State Agency of Environment, Health, and Consumer Protection
(State of Brandenburg, Germany).
2.2. Body weight, body composition and blood glucose measurements
Body weight and blood glucose were measured weekly in the morn-
ing (8–10 a.m.) of a feeding day. Body fat and leanmasswere determined
with a nuclearmagnetic resonance spectrometer EchoMRI (EchoMedical
Systems).
2.3. Indirect calorimetry
Respiratory quotient (RQ) was measured by indirect calorimetry as
described before [24]. Carbohydrate and lipid oxidation were calculated
according to the following equations: Carbohydrate oxidation [g/min]=
4.55 ∗ VCO2− 3.21 ∗ VO2; and Lipid oxidation [g/min] = 1.67 ∗VO2−
1.67 ∗ VCO2 [25].
2.4. Plasma parameters and pancreatic insulin
Plasma triglycerides, glycerol, non-esteriﬁed fatty acids and insulin
as well as pancreatic insulin were measured as described before [26].
2.5. In vivo lipolysis assay
In vivo lipolysis was measured as described before [27]. Brieﬂy,
7 week old mice were fed ad libitum overnight, followed by a 2 hour
fasting period. Thereafter, mice were ip injected with 0.1 mg CL
316,243 per kg body weight (Sigma-Aldrich), a β3-adrenergic receptor
agonist. Plasma glycerol and non-esteriﬁed fatty acids were measured
before and 5, 10, 15, 30 and 60 min after the administration of CL
316,243 and normalized to body fat mass.2.6. Ex vivo palmitate oxidation
Fatty acid oxidation of isolated extensor digitorum longus (EDL) and
soleus muscles was measured essentially as described before [28,29].
2.7. Glucose and insulin tolerance tests
Eight to nine week old mice were either fasted overnight (oGTT) or
for 2 h (ITT), and received an oral glucose bolus (3 g/kg leanmass) or an
insulin injection (1.7 U/kg lean mass). Blood glucose and insulin levels
were measured before and after administration.
2.8. Immunohistochemistry
Parafﬁn sections of livers were stained with antibody against PLIN2.
Nuclei were stainedwith TO-PRO3 iodide (1:500), andAlexa Fluor 488-
F(ab′)2 fragment of goat anti-guinea pig IgG(H + L) (Invitrogen) was
used as secondary antibody. Sections were analyzed by a Leica TCS
SP2 Laser Scan inverted microscope.
2.9. Quantitative real-time PCR
QRT-PCR was performed as described before [24] using correspond-
ing TaqManprobes (Table 1). Gene expressionwas calculated as 2−ΔΔCT
and expressed relative to the AL control group.
2.10. Western blot analysis
Western blot analysis was performed as described before [26] using
appropriate antibodies (Table 2).
2.11. Tissue lipid measurements
Liver and skeletalmuscle triglyceridesweremeasured as described
before [29]. The DAG extraction and ceramide extraction were per-
formed by a modiﬁed method of Merrill [30]. Tissue (80 mg) was sup-
plemented with internal standards (glyceryltritridecanoate, N-
heptadecanoyl-D-erythro-sphingosine, 1-heptadecanoyl-2-hydroxy-
sn-glycero-3-phosphocholine, 1-o-pentadecanyl-3-(9Z-octadecenoyl)-
sn-glycerol, 1,3(d5)-dipentadecanoyl-glycerol, 1,2-di-O-tridecyl-sn-
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phosphorylcholine (purchased from either Sigma Aldrich or Avanti
Polar Lipids)), homogenized in MeOH/CHCl3 (2/1 (vol/vol)), incubated
at 48 °C for 12 h and centrifuged at 3500 ×g (10min, 4 °C). Supernatant
was dried and resuspended in MeOH/IPA, 4/6 (vol/vol), 5 mM NH4Ac
for analysis by LC–MS/MS. Samples were separated on a Kinetex XB-
C18 150 mm × 2.1 mm × 1.7 μm column (Phenomenex®) with a ﬂow
rate of 300 μl/min. Quantitative analysis was performed with the mass
spectrometer (ESI-qToF, maXis® 3G (Bruker Daltonic GmbH))
operated in positive ionization mode. Lipid species were identiﬁed by
means of standard substances, MS/MS-spectra and the Lipidmaps
database.
2.12. Isolation of LD, cytosolic and membrane fractions from liver
Subcellular fractionation of fresh livers (200 mg) was performed as
described before [31]. Tissuewas homogenized in 1600 μl of homogeni-
zation buffer A (20 mM Tris–HCl (pH 7.4), 1 mM EDTA, 0.25 mM EGTA,
250 mM sucrose, protease and phosphatase inhibitors (Roche)),
overlayed with 400 μl of 3% sucrose and centrifuged at 100,000 ×g for
1 h at 4 °C. The lipid cake was removed with a 23-G1 needle, and cyto-
plasm was transferred to a fresh tube. The remaining pellet was resus-
pended in 700 μl buffer B (20 mM Tris HCl (pH 7.5 at 4 °C), 150 mM
NaCl, 50 mM NaF, 5 mM NaPPi, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF,
protease and phosphatase inhibitors (Roche)). Subsequently, samples
were homogenized with a 25-G needle and centrifuged at 20,800 ×g
for 15 min at 4 °C. The remaining LD fraction was removed with a 24-G
needle and Triton-X was added to 2% (vol/vol) to the supernatant.
Membrane samples were passed through a 27-G needle and incubated
for 30 min on ice before being centrifuged at 20,800 ×g for 15 min at
4 °C. Following, pellet was resuspended in 80 μl buffer B. Proteins in
LD fraction were precipitated in acetone at−80 °C overnight, followed
by a centrifugation at 20,800 ×g for 30 min at 4 °C. Protein pellet was
dried and resuspended in buffer B with 2% Triton X (vol/vol).
2.13. Protein identiﬁcation by LC–MS
Equal amounts of protein from LD fractions (20 μg) were digested
with LysC and trypsin. After digestion peptide samples were desalted
by solid phase extraction (SPE), using C18 empore disc cartridges
(Supelco). Desalted peptide mixtures were separated by reversed
phase chromatography using the Dionex Ultimate 3000 nanoLC on in-
house manufactured 25 cm fritless silica microcolumns with an inner
diameter of 75 μm. Columns were packed with the ReproSil-Pur C18-
AQ 3 μmresin. Peptideswere separated on a 5–60% acetonitrile gradient
(90min)with 0.1% formic acid at a ﬂow rate of 200 nl/min. Eluting pep-
tides were ionized online by electrospray ionization and transferred
into an LTQ Orbitrap Velos mass spectrometer. After MS and MS/MS
acquisition raw ﬁles were analyzed using MaxQuant version 1.3.0.5.
The MS/MS spectra were matched against Uniprot mouse database
and 248 frequently observed laboratory contaminants as provided by
the MaxQuant software package, and calculated using the MaxQuant
search engine Andromeda [32].
2.14. Microarray analysis
Liver transcriptome analysis was performed by OakLabs (Berlin,
Germany) using a SurePrint G3 Mouse GE 8 × 60 k chip (Agilent
Technologies).
2.15. Statistical analysis
Statistical analysis was performed by either one-way ANOVA or
two-way ANOVA, or by the unpaired Student t test or Mann–Whitney
test using the software Prism 6 from GraphPad Software (USA). Signiﬁ-
cance levels were set for P-values b 0.05 (*), 0.01 (**) and 0.001 (***).3. Results
3.1. Caloric restriction and intermittent fasting prevent the development
of hyperglycemia
Male NZO mice on a high-fat diet (HFD) were subjected to different
feeding patterns (Fig. 1A). CR mice received 90% of the food consumed
by ad libitum fed control mice (AL), and IF mice had access to food ad
libitum only every other day. The average food intake of AL control
mice was 4.8 ± 0.1 g/day and of CR mice 4.3 ± 0.1 g/day (Fig. 1B). On
feeding days, IF mice consumed 6.9 ± 0.1 g/day (+41% compared to
AL mice) resulting in a decline of cumulative food intake by 27%
(Fig. 1C). Body mass development and lean mass development in CR
and IF mice were reduced (Fig. 2A,B). IF mice displayed also lower
body fat mass compared to AL controls (Fig. 2C). Already after
5 weeks on HFD, AL mice developed hyperglycemia (blood glucose
concentration N 16.6mM; Fig. 2D). At 14weeks of age thediabetes prev-
alencewas 43% for ALmice, whereas not a singlemouse of the CR and IF
groups became diabetic (Fig. 2D).
3.2. Intermittent fasting improved insulin sensitivity
Glucose and insulin tolerance tests were performed 4 weeks after
initiation of the interventions. In oral glucose tolerance tests (oGTTs)
all mice showed similar blood glucose excursions (Fig. 2E). However,
plasma insulin levels during oGTT were lower in the CR and IF groups
(Fig. 2F). Insulin tolerance tests (ITTs) revealed higher insulin sensitivity
only in animals of the IF group (Fig. 2G). Fasting insulin levels of IFmice
were 37% lower than those of AL mice (0.59 ± 0.07 μg/l vs. 0.94 ±
0.15 μg/l, P = 0.051), whereas insulin levels of CR mice (1.08 ±
0.15 μg/l) were similar to AL controls (Fig. 2H). HOMA-IR index was
higher in AL (17.9 ± 7.4) than in IF mice (5.0 ± 0.7; P b 0.05 vs. AL
and CR mice) and did not show signiﬁcant differences in CR mice
(12.5 ± 3.2; P = 0.741 vs. AL mice).
3.3. Intermittent fasting improved metabolic ﬂexibility
AL mice showed a nearly stable respiratory quotient (RQ) of about
0.94 ± 0.04 indicating the predominant oxidation of carbohydrates
(Fig. 3A). CR mice displayed slightly increased RQ in the dark and
lower RQ at the end of the light phase (Fig. 3A). IFmice had a constantly
low RQ (≈0.7) at fasting, and high RQ (≥1.0) at feeding times suggest-
ing increased lipogenesis from carbohydrates (Fig. 3A). The calculation
of carbohydrate and lipid oxidation performed as described by Frayn
[25], conﬁrmed the exclusive utilization of carbohydrates during feed-
ing and lipids during fasting periods, and shows a fast switch between
carbohydrate and lipid metabolism in IF animals (Fig. 3B,C). In compar-
ison to AL, CR mice showed also an improved rhythm of carbohydrate
and lipid metabolism (Fig. 3B,C). In order to test whether the rapid
switch of metabolic pathways is only due to the severe fasting/feeding
rhythm or an adaptation of IF mice, we subjected AL mice to a 24 hour
fasting/feeding pattern. Although AL mice were responsive to fasting
(RQ≈ 0.7), they did not show a similar change from lipid to carbohy-
drate oxidation (or vice versa) as IF animals (Fig. 3D). Thus, IF results
in an adaptive metabolic response to feeding/fasting cycles and a
pronounced rhythm in substrate utilization, a so-called metabolic ﬂexi-
bility. Accordingly, mRNA of lipogenic acetyl-Coenzyme A carboxylase
alpha (Acaca) and stearoyl-Coenzyme A desaturase 1 (Scd1) was
strongly up-regulated in the white adipose tissue (WAT) of the IF
group, but was not altered by CR in comparison to the AL control
(Fig. 3E). Levels of lipolytic hormone sensitive lipase (Lipe) were higher
in WAT of IF animals, whereas those of adipose triglyceride lipase
(Pnpla2) were not changed by CR or IF (Fig. 3E).
Elevated Lipe expression indicates an increased release of free fatty
acids fromWAT. In fact, injection of the β3-adrenergic receptor agonist
CL-316,243 resulted in an increase of plasma glycerol and free fatty
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slightly elevated in CR mice (Fig. 3F,G). Thus, our data demonstrate an
increased capacity of adipocyte lipolysis in animals subjected to IF.
3.4. Intermittent fasting reduced speciﬁc diacylglycerols by increasing fatty
acid oxidation in glycolytic muscles
We next analyzed the lipid proﬁle of muscle and liver at the age of
11–13 weeks. In muscle, the levels of triglycerides (Fig. 4A) as well as
of ceramides (Fig. 4B) were not affected by CR or IF, whereas the diacyl-
glycerol (DAG) concentrationswere signiﬁcantly reduced in IFmice and
showed a similar tendency but no signiﬁcant effects in the CR group
(P= 0.114) (Fig. 4C). Among 23 DAG species analyzed, 16 were detect-
ed in skeletal muscle of NZO mice (Fig. 4D). The majority of DAGs was
represented by 5 distinct species (DAG-16:0-18:1, DAG-16:0-18:2,
DAG-18:1-18-1, DAG-18:1-18:2, DAG-20:4-16:0), which were all
signiﬁcantly reduced in IF muscles. Muscles from CR mice exhibited a
tendency of reduced concentrations of these particular DAG species
(P-values 0.100–0.147), however, DAG-20:4-18:0 was signiﬁcantly
reduced by both, CR and IF (Fig. 4D).To elucidate whether the reduction of DAGs is the result of an
increased fatty acid oxidation, we measured palmitate oxidation in
isolated extensor digitorum longus (EDL) and soleus muscles. In soleus
muscles, no difference in palmitate oxidation between the groups was
observed (Fig. 4E). In EDL muscles, however, beta-oxidation of IF mice
was increased by 114% (P = 0.076) at basal conditions, and by 60%
(P b 0.01) upon AMPK activation by AICAR (Fig. 4E). CR tended to
increase palmitate oxidation in EDL muscle, albeit to a lower extent
(48% increment basal, P = 0.392; 41% increment AICAR-stimulated,
P = 0.057; Fig. 4E).
3.5. Intermittent fasting reduced hepatic diacylglycerol levels and
PKCε activity
In comparison to AL, CR and IF mice exhibited much smaller hepatic
lipid droplets (LDs) as indicated by staining of PLIN2 (Fig. 5A). Hepatic
triglyceride content was signiﬁcantly reduced in IF mice, whereas CR
animals showed only a similar tendency but did not reveal signiﬁcant
effects (P = 0.175) (Fig. 5B). Ceramide levels were not affected by CR
or IF (Fig. 5C), but a 2-fold decrease in DAG content in livers of IF mice
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570 C. Baumeier et al. / Biochimica et Biophysica Acta 1851 (2015) 566–576was detected (Fig. 5D). DAG levels of CR livers were similarly but not
signiﬁcantly reduced (P = 0.062). Among 24 detected DAG species we
found 9 (DAG-16:0-18:0, DAG-16:0-18:2, DAG-18:0-18:0, DAG-18:0-
18:1, DAG-18:1-18:1, DAG-18:1-18:2, DAG-20:1-18:0, DAG-40:4,
DAG-40:7) to be signiﬁcantly reduced by IF, of which DAG-40:4 and
DAG-40:7 showed also signiﬁcant effects after CR (Fig. 5E). Among the
major changes in DAG species, 5 (DAG-16:0-18:0, DAG-16:0-18:2,
DAG-18:0-18:1, DAG-18:1-18:1, DAG-18:1-18:2) were overlappingand simultaneously reduced in liver and muscle of IF mice. A known
consequence of increased hepatic DAG levels is the activation of PKCε
by its translocation to the plasma membrane where it inhibits insulin-
receptor kinase activity [3]. Actually, decreased hepatic DAG concentra-
tion of IF mice was linked to lower PKCε levels in the membrane
fractions indicating a reduced PKCε activity (Fig. 5F). CR also reduced
PKCε content in membranes, however, to a lower not signiﬁcant extent
(P = 0.085).
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LD composition
As LD proteins are involved in maintaining lipid homeostasis and
protection from lipotoxicity, we isolated LDs from livers of the three
groups at the age of 11–13 weeks and analyzed their proteome by LC–
MS. Fig. 6A shows Western blot analysis of the isolated fractions (LDs,
membranes, cytosol) and demonstrates that each fraction was enriched
with correspondingmarker proteins. CGI-58 andATGLwere detected in
LD fractions. Plasma membrane, ER and Golgi-speciﬁc proteins were
detected in the membrane fraction and the cytosolic GAPDH was
found in the cytosolic fraction. However, each fraction was moderately
contaminated with proteins from other compartments.
By proteomics of LD fractions we detected 613 proteins. Increased
abundance (P b 0.05, fold change ≥ 2.0) at LDs from CR and IF livers
was found for 18 proteins when compared to AL LDs (Fig. 6B). Of
these PSMD9, MIF, TCEB2, ACY1 and FABP5 showed signiﬁcantly higher
levels in LDs of the CR and IF groups. KPNBP1, ATG3, DAP, MPST, ADH4,
TTPA, EIF5, CALD1, CORO1b and ISOC1were signiﬁcantly elevated in LDfractions of IF livers and showed a similar tendency in CR fractions. Three
proteins (GAMT, THRSP and CDV3) exhibited higher abundance in the
LD compartment after CR with a similar tendency in IF samples. Four
proteins (GSTA3, UOX, CROT and A2LD1) were reduced in the LD frac-
tion of livers from CR and IF mice (Fig. 6C). Array-based transcriptomics
of the same livers showed that onlyﬁve of the transcripts (Psmd9,Kpnb1,
Cdv3, Uox and Crot) exhibited signiﬁcantly altered expression between
the three groups, of which only three (Psmd9, Kpnb1 and Crot) were al-
tered in the same direction as detected by the proteomic approach
(Fig. 6D,E). However,Western blot analyses performedwith liver lysates
demonstrated that the total amount of PSMD9, MIF and FABP5 proteins
was not elevated in response to CR and IF. It rather appears that the
protein expression of FABP5 is slightly reduced in IF livers (Fig. 6F).
4. Discussion
The present study demonstrated that a moderate caloric restriction
by 10% has the same beneﬁcial effect in preventing T2D in the NZO
mice as a very strict intervention, the intermittent fasting. However,
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575C. Baumeier et al. / Biochimica et Biophysica Acta 1851 (2015) 566–576the molecular mechanisms responsible for preventing hyperglycemia
are still not entirely clariﬁed. Beneﬁcial effects of IF are signiﬁcantly
associated with alterations in hepatic LD protein composition and the
reduction of DAG species in liver and muscle, and these effects show
at least the same tendency in the CR group. It can be speculated that
an altered LD composition in IF livers participates in the reduction of
DAG concentrationswhichprevent the activation of PKCε and inhibition
of insulin signaling. Another reason for the prevention of T2D by CR and
IF could be the slightly reduced body weight.
Storage and hydrolysis of intracellular fat are regulated by proteins
associated with LDs. As lipid-derived metabolites cause progressive
lipotoxicity and insulin resistance, LD proteins are important targets in
protection from lipotoxic events and consequently from non-alcoholic
fatty liver disease (NAFLD), insulin resistance and T2D [33]. Earlier
studies have already identiﬁed LD proteins in rat and mice livers [34,
35] of which 84% overlap with proteins we identiﬁed in our approach.
The majority of identiﬁed proteins were not classical LD associated
proteins like lipases or PLINs. Since LDs closely interact with other
subcellular organelles, some of the identiﬁed proteins may actually be
contaminants during preparation, but we assume that such contamina-
tions are similar in all groups. However, a number of proteins in the LD
fraction were markedly affected by CR and IF. Interestingly, most of
these proteins were altered in their LD abundance rather than in their
mRNA expression indicating an impact of caloric restriction and fasting
on the localization, stability or degradation of particular proteins. As it is
suggested that the proteome of individual LDs is different [36], it is pos-
sible that the metabolic state determines either the pattern of proteins
associated with particular LDs or the composition of different subpopu-
lations of LDs within the liver.
Among the differentially abundant proteins, 18were elevated at LDs
of CR and IF mice, of which ﬁve (PSMD9, MIF, TCEB2, ACY1 and FABP5)
exhibited similar and signiﬁcant effects in both groups and are therefore
the most likely candidates to play a role in mediating protective effects
when localized at hepatic LDs. GSTA3 (glutathione S-transferase alpha
3) is a candidate that might exhibit a negative effect on LDs, because
its abundance on LDs of CR and IF livers was signiﬁcantly decreased.
The strongest effect was seen with the co-activator Bridge-1 (PSMD9),
which is in linkage with T2D, T2D-nephropathy and macrovascular
pathology in Italian families [37]. PSMD9 transduces signals that
regulate insulin production, proliferation, and survival of pancreatic
beta-cells [38], and pancreatic overexpression of Psmd9 results in insu-
lin deﬁciency and T2D [39]. However, hepatic PSMD9 and its role at LDs
are not yet known. As PSMD9 is a proteasomal chaperone it can be
speculated that in the CR and IF states LDs are associated with the
proteasome to be degraded. Along this line we also identiﬁed ATG3,
an ubiquitin-like-conjugating enzyme to be elevated in LD fractions of
IFmicewhich could indicate that prolonged fasting regimens accelerate
the degradation of lipids through the lysosomal degradative pathway of
autophagy, designated lipophagy [40]. Macrophage migration inhibitor
factor (MIF) was also elevated at LDs of CR and IF livers.Mif-deﬁcient
mice develop hyperglycemia and glucose intolerance [41], and adminis-
tration ofMIF to human hepatocytes reduced lipid accumulation [42]. In
addition, there is evidence that exercise as well as CR induces Mif
expression in murine livers [42,43]. As we did not observe differences
in hepatic Mif mRNA and protein expression after CR and IF, our data
suggest a role of MIF in regulating hepatic lipid metabolism by its
recruitment to LDs. Also the fatty acid binding protein 5 (FABP5) was
more abundant at LDs of CR and IF mice. In contrast, its protein expres-
sion was rather decreased in total liver lysates of IF mice, supporting its
increased localization at LDs in these animals. FABP5 is a member of
fatty acid carrier proteins that facilitate the transfer of fatty acids be-
tween extra- and intracellularmembranes. Increased FABP5 association
with LDs after CR and IF suggests an elevated transport of fatty acids to/
from LDs and thereby indicates an increased lipid turnover.
Another interesting effect we detected especially in the IF group,
was the reduced level of muscular and hepatic DAGs. Previous studieshave found that reducing calories rapidly decreases hepatic fat content
and improves insulin sensitivity in T2D patients [2,3]. In these studies,
similar to our ﬁndings, DAGs but not ceramides correlated with insulin
sensitivity. Moreover, we showed that the reduction of hepatic DAGs is
linked to a decreased PKCε activation in livers of CR and IFmice suggest-
ing a direct effect to improved insulin sensitivity in these animals.
Among the different DAG species DAG-20:4-18:0 in muscle and DAG-
40:4 andDAG-40:7 in liverwere signiﬁcantly reduced by both interven-
tions, and several DAG-16 andDAG-18 species showed similar effects in
these tissues. Thismight indicate that particularly these speciesmediate
negative effects on insulin sensitivity under conditions of overnutrition.
The diminished DAG content appears to be the result of a combination
of a decreased energy intake, and an increased mitochondrial beta-
oxidation as detected in EDL muscles of IF mice. In agreement, previous
studies in mice [44] and humans [45] demonstrated an induced lipid
oxidation by IF. Thus, our data link an increased lipid oxidation by IF
to the reduction of ectopic accumulation of intracellular DAGs. In
summary, we showed that extended fasting enhances lipid oxidation
in glycolytic muscles, which in turn affects DAG accumulation and
insulin sensitivity, presumably via reduced activation of novel PKCs.
Beneﬁcial anti-diabetic effects of CR and IF can also be the conse-
quence of other changes that only reach signiﬁcance after the strict in-
termittent fasting procedure. This could be the case for the improved
metabolic ﬂexibility that might participate in the enhancement of insu-
lin sensitivity. The change of caloric intake and feeding rhythm is known
to inﬂuence metabolism and source of energy which is preferentially
utilized. Feeding aHFD ad libitum results in a disturbed feeding behavior
with frequent food intake throughout day and night. In addition,
NZO mice are genetically predisposed for hyperphagia [46]. A study in
HFD-fed C57BL/6Jmice showed a protection against diet-induced obesi-
ty, hyperinsulinemia, hepatic steatosis, and inﬂammation by restricting
feeding to an 8 hour period per day without reducing calories [47]. In
our study CR and IF also limited feeding to a particular time interrupted
by different fasting periods in between. Thus, it is likely that CR and IF
improve feeding rhythm – for instance by affecting satiety – leading to
protective effects on metabolism. However, we did not expect that
(1) the CR mice did not react with a reduced fat mass (Fig. 2) and
(2) glucose clearance during oral glucose tolerance tests was not
improved by CR and IF (Fig. 3). The fact that insulin concentrations dur-
ing the glucose challenge were signiﬁcantly lower in IF with a similar
tendency in CR indicates that limiting food intake improves insulin sen-
sitivity, presumably as a consequence of lower ectopic fat accumulation
in the liver (Fig. 5). Accordingly, an improved insulin tolerance could be
detected at least for the IF mice (Fig. 2).
5. Conclusion
In summary, we found that a moderate caloric restriction as well as
an intermittent fasting are suitable to prevent the onset of type 2 diabe-
tes in NZO mice. Although suppression of diabetes by these interven-
tions has been shown before, this is the ﬁrst study linking changes in
hepatic lipid droplet proteome and levels of speciﬁc diacylglycerols to
improved insulin sensitivity and protection from hyperglycemia and
beta-cell loss, however, without showing causality. This ﬁnding may
prompt further studies aiming to understand the role of particular
lipid droplet proteins in the regulation of hepatic insulin sensitivity.
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